Adenocarcinoma of the fallopian tube. Experience with 41 patients.

PubWeight™: 0.94‹?›

🔗 View Article (PMID 412144)

Published in Obstet Gynecol on December 01, 1977

Authors

J L Benedet, G W White, R N Fairey, D A Boyes

Articles by these authors

Cervical cancer detection in British Columbia. A progress report. J Obstet Gynaecol Br Commonw (1968) 5.43

FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet (2000) 5.33

Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet (2006) 4.76

Organisation and results of the cervical cytology screening programme in British Columbia, 1955-85. Br Med J (Clin Res Ed) (1988) 4.60

A cohort study of cervical cancer screening in British Columbia. Clin Invest Med (1982) 3.80

LY-127935: a novel beta-lactam antibiotic with unusual antibacterial activity. Antimicrob Agents Chemother (1979) 3.49

Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet (2006) 3.25

Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet (2006) 2.47

FIGO staging of gynecologic cancer. 1994-1997 FIGO Committee on Gynecologic Oncology. International Federation of Gynecology and Obstetrics. Int J Gynaecol Obstet (1999) 2.36

The acceptance of the cervical cytology screening programme in the province of British Columbia. J Obstet Gynaecol Br Commonw (1967) 1.96

Invasive cancer of the cervix in British Columbia: a review of the demography and screening histories of 437 cases seen from 1985-1988. Obstet Gynecol (1992) 1.66

Intensive therapy with cyclophosphamide, carmustine, etoposide +/- cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy. Blood (1994) 1.66

The results of treatment of 4389 cases of preclinical cervical squamous carcinoma. J Obstet Gynaecol Br Commonw (1970) 1.66

The evaluation of cancer control measures. Br J Cancer (1973) 1.60

Carcinoma of the vulva. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet (2006) 1.54

Ten-year outcome of patients with advanced epithelial ovarian carcinoma treated with cisplatin-based multimodality therapy. J Clin Oncol (1992) 1.51

FIGO staging of gynecologic cancer. 1994-1997 FIGO Committee on Gynecologic Oncology. International Federation of Gynecology and Obstetrics. Int J Gynaecol Obstet (1999) 1.49

Comparative in vitro activity of azlocillin, ampicillin, mezlocillin, piperacillin, and ticarcillin, alone and in combination with an aminoglycoside. Antimicrob Agents Chemother (1979) 1.47

Carcinoma of the corpus uteri. J Epidemiol Biostat (2001) 1.42

Carcinoma of the ovary. Int J Gynaecol Obstet (2003) 1.36

Cervical intraepithelial neoplasia in British Columbia: a comprehensive program for detection, diagnosis, and treatment. Gynecol Oncol (1981) 1.31

Carcinoma of the corpus uteri. Int J Gynaecol Obstet (2003) 1.30

Ovarian carcinoma: a multivariate analysis of prognostic factors. Obstet Gynecol (1985) 1.28

Colposcopic accuracy in the diagnosis of microinvasive and occult invasive carcinoma of the cervix. Obstet Gynecol (1985) 1.25

The value of a Pap smear program and suggestions for its implementation. Cancer (1981) 1.24

Gestational trophoblastic neoplasia, FIGO 2000 staging and classification. Int J Gynaecol Obstet (2003) 1.23

Spontaneous infectious discitis in adults. Am J Med (1996) 1.20

Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's disease. J Clin Oncol (1991) 1.16

A case control study into the possible effects of birth control pills on pre-clinical carcinoma of the cervix. J Obstet Gynaecol Br Commonw (1972) 1.11

The Cytology Program in British Columbia: I. An Evaluation of the Effectiveness of Cytology in the Diagnosis of Cancer and its Application to the Detection of Carcinoma of the Cervix. Can Med Assoc J (1962) 1.11

The British Columbia screening program. Obstet Gynecol Surv (1969) 1.09

Carcinoma of the ovary. J Epidemiol Biostat (2001) 1.09

Evolving a strategic approach to cervical cancer control in Africa. Gynecol Oncol (2005) 1.09

A contextual-behavioral model of empowerment: case studies involving people with physical disabilities. Am J Community Psychol (1994) 1.08

Brief chemotherapy and involved field radiation therapy for limited-stage, histologically aggressive lymphoma. Ann Intern Med (1987) 1.04

Carcinoma of the vagina. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet (2006) 1.02

Recent results from the British Columbia screening program for cervical cancer. Am J Obstet Gynecol (1977) 0.99

Glucocorticoid-induced apoptosis of dendritic cells in the rat tracheal mucosa. Am J Respir Cell Mol Biol (1998) 0.99

Experience with cervical screening in British Columbia. Gynecol Oncol (1981) 0.99

The melting sign in resolving transient pulmonary infarction. Am J Roentgenol Radium Ther Nucl Med (1971) 0.99

The performance of fluorescence and reflectance spectroscopy for the in vivo diagnosis of cervical neoplasia; point probe versus multispectral approaches. Gynecol Oncol (2007) 0.98

The clinical effectiveness of optical spectroscopy for the in vivo diagnosis of cervical intraepithelial neoplasia: where are we? Gynecol Oncol (2007) 0.97

Radiation oncology--the misunderstood specialty. J Can Assoc Radiol (1984) 0.96

Accuracy of colposcopy in the diagnostic setting compared with the screening setting. Obstet Gynecol (2008) 0.94

Fatal outcome of pelvic radiotherapy for carcinoma of the cervix in a patient with systemic lupus erythematosis. Clin Radiol (1989) 0.93

Mechanism of tachyphylaxis associated with neurogenic plasma extravasation in the rat trachea. Am Rev Respir Dis (1990) 0.91

Carcinoma of the fallopian tube. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet (2006) 0.90

Outcome of treatment of first relapse of Hodgkin's disease after primary chemotherapy: identification of risk factors from the British Columbia experience 1970 to 1988. Blood (1991) 0.89

Clinical and pathological features and survival of endometrial cancer patients in relation to prior use of estrogens. Gynecol Oncol (1980) 0.89

Forty years of repeated screening: the significance of carcinoma in situ. Br J Cancer (1996) 0.89

The use of exfoliative vaginal cytology in pregnancy. Am J Obstet Gynecol (1966) 0.89

Carcinostatic activity of 4-hydroxy-2-pent-en-1-al against transplantable murine tumour lines. Eur J Cancer (1975) 0.89

Cervical intraepithelial neoplasia in female prisoners in British Columbia. CMAJ (1988) 0.89

Cortisol directly determined in serum by fluoroimmunoassay with magnetizable solid phase. Clin Chem (1980) 0.88

Natural history of cervical intraepithelial neoplasia: a meta-analysis. Acta Cytol (2005) 0.88

Apoptosis in regenerating and denervated, nonregenerating urodele forelimbs. Wound Repair Regen (2000) 0.87

Radical hysterectomy in the treatment of cervical cancer. Am J Obstet Gynecol (1980) 0.86

Plasma cell leukemia following treatment with radiotherapy and melphalan. Can Med Assoc J (1977) 0.86

Treatment of 126 cases of advanced ovarian carcinoma with cyclophosphamide. Can Med Assoc J (1968) 0.86

Granulosa cell tumors. A clinical review of 61 cases. Obstet Gynecol (1978) 0.85

Advantages of routine step serial sectioning of cervical cone biopsies. Am J Clin Pathol (1968) 0.85

The results of cryosurgical treatment of cervical intraepithelial neoplasia at one, five, and ten years. Am J Obstet Gynecol (1987) 0.84

Treatment of advanced endometrial carcinoma with a progestational agent. Am J Obstet Gynecol (1969) 0.83

Cryotherapy in the treatment of cervical intraepithelial neoplasia. Obstet Gynecol (1981) 0.82

Prognostic factors in Paget's disease of the vulva: a study of 21 cases. Int J Gynecol Pathol (1999) 0.81

The performance of human papillomavirus high-risk DNA testing in the screening and diagnostic settings. Cancer Epidemiol Biomarkers Prev (2008) 0.81

Colposcopy, conization, and hysterectomy practices: a current perspective. Obstet Gynecol (1982) 0.81

Effects of omeprazole paste on healing of spontaneous gastric ulcers in horses and foals: a field trial. Equine Vet J Suppl (1999) 0.81

In situ squamous carcinoma of the uterine cervix. Can Med Assoc J (1968) 0.81

Carcinoma in situ of the vagina. Am J Obstet Gynecol (1984) 0.81

In vitro comparison of three new cephalosporins: LY-127935, cefotaxime and cefoperazone. Chemotherapy (1981) 0.81

The clinical effectiveness of fluorescence and reflectance spectroscopy for the in vivo diagnosis of cervical neoplasia: an analysis by phase of trial design. Gynecol Oncol (2007) 0.80

Why cancer staging? FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet (2006) 0.80

Testicular lymphoma: improved outcome with early brief chemotherapy. J Clin Oncol (1988) 0.80

The follow-up of 141 cases of untreated invasive cervical carcinoma. Trans Pac Coast Obstet Gynecol Soc (1971) 0.80

Differential effects of phosphoramidon and captopril on NK1 receptor-mediated plasma extravasation in the rat trachea. Agents Actions (1994) 0.80

An analysis of maternal deaths in British Columbia: 1963 to 1970. Can Med Assoc J (1974) 0.79

Treatment of advanced endometrial carcinoma with tamoxifen. N Engl J Med (1979) 0.79

Calcitonin gene-related peptide potentiates substance P-induced plasma extravasation in the rat trachea. Lung (1992) 0.79

Squamous carcinoma in situ of the vulva. Gynecol Oncol (1982) 0.79

Intermittent pelvic infusion with vincristine, bleomycin, and mitomycin C for advanced recurrent carcinoma of the cervix. Cancer Treat Rep (1979) 0.78

Gestational trophoblastic neoplasia. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet (2006) 0.78

Carcinoma of the vulva. Int J Gynaecol Obstet (2003) 0.78

Squamous carcinoma of the vulva: results of treatment, 1938 to 1976. Am J Obstet Gynecol (1979) 0.78

Preliminary report of a clinical trial of the treatment of patients with advanced stage III and IV ovarian cancer with melphalan, 5-fluorouracil, and methotrexate in combination and sequentially: a study of the Clinical Trials Group of the National Cancer Institute of Canada. Cancer Treat Rep (1979) 0.78

[Detection of cervical cancer: report of the Canadian Working Group, 1982]. Union Med Can (1982) 0.78

Carcinoma of the vulva. J Epidemiol Biostat (2001) 0.77

The accuracy of the Papanicolaou smear in the screening and diagnostic settings. J Low Genit Tract Dis (2008) 0.77